|
|
|
Company Name
|
Supernus Pharmaceuticals, Inc.
|
|
Drug Name
|
SPN-804 (NDA)
|
|
Event Name
|
FDA decision on SPN-804 for epilepsy
|
|
Event Date
|
10/19/2012
|
|
Outcome
|
FDA approved Oxtellar XR, formerly SPN-804, for epilepsy on Oct.19, 2012
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|